Perspective
Our work in Perspective
-
Proposition 3 Could Provide New Resources for Utahns with Diabetes
An overlooked factor in the debate over Proposition 3 is the impact that an expansion of Utah’s Medicaid program would have on the state’s diabetes epidemic, argues Rebecca Myerson in an op-ed in the Salt Lake Tribune.
Categorized in -
Comments on CMS’s Proposed Rule, “Medicare Shared Savings Program; Accountable Care Organizations–Pathways to Success”
Schaeffer fellow Matthew Fiedler submitted a comment letter to Centers the for Medicare and Medicaid Services on proposed rule changes to the Medicare Shared Savings Program. Some proposals may result in cost-savings and greater efficiencies, Fiedler recommends additional analysis in a number of areas.
Categorized in -
Analyzing New Bipartisan Federal Legislation Limiting Surprise Medical Bills
The Schaeffer Initiative researchers discuss bipartisan draft legislation that some say marks an important step forward in putting an end to surprise medical bills nationwide.
Categorized in -
Payment and Delivery-System Reform — The Next Phase
In The New England Journal of Medicine, Paul Ginsburg discusses the next phase of value-based payment systems and how healthcare payers and purchasers can ensure providers’ past investments become permanent reforms to the payment and care delivery process.
Categorized in -
Blame Emergency Rooms for the Out-of-Control Cost of Health Care
Glenn Melnick argues hospital groups and public policy are to blame for exorbitant emergency room costs for patients in an op-ed for The New York Times.
Categorized in -
Trump Might Actually Lower Drug Prices
Dana Goldman and Anupam Jena write in The Washington Post that the Trump administration may succeed in lowering drug prices by fostering competition and innovation, and possibly ending kickbacks in the supply chain.
Categorized in -
When We Find a Cure, Price it Like Netflix to Ensure Access
Dana Goldman and his colleagues have shown that such subscription models can improve outcomes and save money at the same time.
Categorized in -
An Economist’s Change of Heart: It’s Time to Regulate the Prescription- Drug Middlemen
Pharmacy-benefit managers find ways to boost their bottom line at the expense of employers and patients, writes Geoffrey Joyce in Market Watch.
Categorized in -
CMS’ Positive Step on Site-Neutral Payments and the Case for Going Further
The authors argue that site-neutral payment under the CMS proposed rule should ultimately be applied to a much broader set of clinical services.
Categorized in -
To Reduce Opioid Prescriptions, Tell Doctors When Their Patients Overdose and Die
Our year-long study found that doctors prescribed fewer opioids after receiving letters telling them their patient had died from an opioid overdose.
Categorized in